Hepatitis E Virus Infection in Hyperbilirubinemia Patients Progressed to Liver Failure in 2003–2021, China
Journal of Viral Hepatitis · 2025
DOI: 10.1111/jvh.70054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2025. Verfasst von Qiyu He und 13 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Blood Center, Shen Zhen, Guangdong, China. Hauptthemen laut MEDLINE: Hepatitis E, Liver Failure, Hyperbilirubinemia. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Beijing Municipal Natural Science Foundation, Sanming Project of Medicine in Shenzen Municipality.
Abstract (Originalsprache)
Hepatitis E virus (HEV)‐related liver failure is increasingly reported. Patients with hyperbilirubinemia usually indicate liver damage and may develop liver failure, but HEV infection in them is less studied. This study aimed to investigate HEV infection in hyperbilirubinemia patients. A total of 949 patients with total bilirubin (Tbil) > 171 μmol/L during 2003–2021 in Beijing Youan hospital were tested for HEV. We found that 10.43% (99/949) patients were positive for anti‐HEV IgM, or/and HEV pathogen markers. After ruling out 10 patients with incomplete data, 64.0% (57/89) progressed to liver failure. Patients with greater end‐stage liver disease model scores tended to develop liver failure and have a poorer prognosis after HEV insult, evidenced by lower recovery/improvement rates. Liver cirrhosis patients with poorer Child‐Turcotte‐Pugh grades also tended to develop liver failure after HEV insult. In liver failure patients, those with HEV infection showed higher proportions of fatty liver and recent gastrointestinal haemorrhage than those without HEV infection. In conclusion, HEV infection is not uncommon in patients with Tbil > 171 μmol/L, and hyperbilirubinemia patients with more severe liver diseases are at more risk for liver failure after HEV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen Blood Center, Shen Zhen, Guangdong, China.
- Department of Microbiology and Infectious Disease Centre, School of Basic Medical Sciences, Peking University Health Science Centre, Beijing, China.
- Fourth Department of Liver Disease, Beijing Youan Hospital, Capital Medical University, Beijing, China.
- Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing, China.
Förderung
- National Key Research and Development Program of China
- Beijing Municipal Natural Science Foundation
- Sanming Project of Medicine in Shenzen Municipality
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
He, Q., Dong, J., Huang, L., Gao, Y., Tang, H., Wu, Y., Ding, M., Liang, Z., Liu, T., Yang, X., Yuan, D., Li, Y., Wang, L., & Chen, Y. (2025). Hepatitis E Virus Infection in Hyperbilirubinemia Patients Progressed to Liver Failure in 2003–2021, China. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70054
Vancouver
He Q, Dong J, Huang L, Gao Y, Tang H, Wu Y, et al. Hepatitis E Virus Infection in Hyperbilirubinemia Patients Progressed to Liver Failure in 2003–2021, China. Journal of Viral Hepatitis. 2025. doi:10.1111/jvh.70054
BibTeX
@article{He2025,
author = {He, Qiyu and Dong, Jinling and Huang, Liqin and Gao, Yuan and Tang, Huixin and Wu, Yu and Ding, Mei and Liang, Zhaochao and Liu, Tianxu and Yang, Xinyue and Yuan, Disen and Li, Yuebao and Wang, Lin and Chen, Yu},
title = {Hepatitis E Virus Infection in Hyperbilirubinemia Patients Progressed to Liver Failure in 2003–2021, China},
journal = {Journal of Viral Hepatitis},
year = {2025},
doi = {10.1111/jvh.70054}
}
EUVIMED